Back to Top Skip to main content

CBD oil off limits for service members

A service member checks the label on a supplement. Service members must remain diligent and check labels on consumer products and follow official guidance on CBD products. (U.S. Air Force photo by Staff Sgt. Nicole Leidholm) A service member checks the label on a supplement. Service members must remain diligent and check labels on consumer products and follow official guidance on CBD products. (U.S. Air Force photo by Staff Sgt. Nicole Leidholm)

Recommended Content:

Armed Forces Medical Examiner System | Substance Abuse

DOVER AIR FORCE BASE, Del. — Water, tea, coffee, chocolates, gummies, oils, honey, and vaping oils are just some of the seemingly innocent products that could ruin a service member’s career.

These products are being seen more on the market since Cannabidiol or CBD oil use has become more widespread across America.

The Department of Defense has a zero tolerance policy for the illegal or improper use of drugs by service members, which includes CBD oil.

“It is common to see advertisements where CBD is listed as a treatment for many conditions, when in fact, there are very limited human studies,” said Dr. Erin Karschner, Armed Forces Medical Examiner System forensic toxicologist. “Researchers are also unsure of how CBD interacts with other medications that people may be taking and if adverse effects may occur after using CBD, particularly when CBD products are used for long periods of time.”

Cannabidiol is a non-intoxicating chemical in the cannabis plant.

Another component of the cannabis plant is THC, or delta-nine-tetrahydrocannabinol, which is the chemical responsible for giving the high sensation cannabis users experience.

On December 20, 2018, the President signed into law the Agriculture Improvement Act of 2018, known as the 2018 Farm Bill, which defined hemp as cannabis containing no more than 0.3 percent THC by dry weight and legalized the production of hemp and the sale of its products. Cannabis containing more than 0.3 percent THC is still considered a Schedule I controlled substance.

Prior to December 2018, hemp was a Schedule I controlled substance under the Controlled Substances Act of 1970.

“Even if CBD extract contains 0.3 percent or less of THC, service members put themselves at risk if they consume these products without being prescribed an [Food and Drug Administraion]-approved product by a medical professional,” said Air Force Capt. Marcus Walker, 436th Airlift Wing Assistant Staff Judge Advocate. “There are very few products that have been approved by the FDA, so the vast majority of CBD products we see on the market on a day to day basis remain federally illegal.”

The Division of Forensic Toxicology at the Armed Forces Medical Examiner System is responsible for the laboratory testing of blood, urine, and tissue specimens submitted as part of military investigations.

“In our laboratory, we test for drugs of abuse, novel psychoactive substances and therapeutic pharmaceuticals,” said Karschner. “We perform an extraction where we are able to pull the cannabinoids out of the blood and urine, concentrate those compounds, and analyze them on a sensitive instrument where we can determine exactly which cannabinoids are present in the specimen.”

There are no FDA regulations in place for CBD products and there is no mandated oversight or quality control for these products.

“This means products may contain CBD in lower or higher amounts than what is on the product label or they may contain additional unexpected active ingredients, heavy metals, or pesticides,” said Karschner. “Products may contain more THC than expected and have the potential to cause a positive urine drug test and intoxication, which may affect military readiness. These products may also be adulterated with other active components, like synthetic cannabinoids, which may lead to intoxication and accidents.”

Even while hemp has been legalized in the U.S., the use of hemp and CBD products are still prohibited for use by service members.

“The fact remains that CBD products remain heavily unregulated throughout the United States,” said Walker. “This means we don’t actually know what is and isn’t in these products.”

Each of the services have implemented their own guidance with regard to hemp product use. It is important that service members are familiar with and follow service-specific regulations. Regulations can be found at: AR600-85 section 4-2 (Army); AFMAN 44-197, section 1.2.2.1 (Air Force); ALNAV 057/19 (Navy and Marine Corps); and COMDTINST M1000.10, Chapter 5, section D.1 (Coast Guard).

“Bottom line, even if legal on the state level, and even if the label of the CBD product states there is no THC content, CBD use remains prohibited for military members,” said Walker. “Current Air Force policy prohibits all marijuana derivatives, including hemp. If they use it, they risk a positive result for THC on a drug test, and as a result, they could ultimately face administrative or criminal action.”

Disclaimer: Re-published content may be edited for length and clarity. Read original post.

You also may be interested in...

DHA PI 6025.15: Management of Problematic Substance Use by DoD Personnel

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (aa), establishes the Defense Health Agency’s (DHA) procedures to assign responsibilities for problematic alcohol and drug use identification, diagnosis, and treatment for DoD military personnel.

  • Identification #: 6025.15
  • Date: 4/16/2019
  • Type: DHA Procedural Instruction
  • Topics: Substance Abuse

DHA PI 6490.02: Behavioral Health (BH) Treatment and Outcomes Monitoring

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (k): a. Establishes the Defense Health Agency’s (DHA) procedures for the collection and analysis of BH outcome data. b. Addresses how DoD will standardize BH outcome data collection to: assess variations in mental health and substance use care among in-garrison medical treatment facilities (MTFs) and clinics; assess the relationship of treatment protocols and practices to BH outcomes; and identify barriers to provider implementation of evidence-based clinical guidance approved by DoD. c. Designates the Army as the DoD lead Service for maintenance and sustainment of the Behavioral Health Data Portal (BHDP) in specialty care mental health and substance use clinics, referred to collectively as BH clinics, until BHDP functionality can be integrated with GENESIS or another electronic health record (EHR) system managed by DHA. d. Designates DHA Information Operations (J-6) as lead on transitioning BHDP functional requirements related to outcomes monitoring to future EHR data collection platforms and processes.

DHA PI 6025.04: Pain Management and Opioid Safety in the MHS

Policy

The purpose of our MHS Pain Management Campaign is to enable Clinical Communities to provide evidence-based pain management guided by clinical practice guidelines (CPGs): effectively treat acute and chronic pain; promote non-pharmacologic treatment; prevent acute pain from becoming chronic; and minimize use of opioids with appropriate prescribing only when indicated. The Pain Management Clinical Support Service achieves these ends through clinical improvements in pain care, clinician and patient education, and research. This Defense Health Agency-Procedural Instruction (DHA-PI) is a dual effort between the Pain Management Clinical Support Service and the Clinical Communities to achieve our stated purpose through implementation of the MHS Stepped Care Model.

DoD Instruction 5154.30: Armed Forces Medical Examiner System AFMES Operations

Policy

This instruction establishes policy, assigns responsibilities, and provides direction for forensic medicine activities throughout DoD In accordance with the authority in DoD Directive (DoDD) 5124.02, and provides for the continued operation and governance of AFMES, a component of the Defense Health Agency (DHA) under DoDD 5136.13, in carrying out assigned functions, including those under Section 1471 of Title 10, United States Code (U.S.C.).

DoD Instruction 1010.04: Problematic Substance Use by DoD Personnel

Policy

Establishes policies, assigns responsibilities, and prescribes procedures for problematic alcohol and drug use prevention, identification, diagnosis, and treatment for DoD military and civilian personnel.

  • Identification #: DoD Instruction 1010.04
  • Date: 2/20/2014
  • Type: Instructions
  • Topics: Substance Abuse
Showing results 1 - 5 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.